October 12, 2008
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for April 25, 2005 Subscribe to this News Feed  
 

New Hope for People with Diabetes, Lupus, Some Forms of Cancer, and other Inflammatory Diseases

Download this press release as an Adobe PDF document.

A specially designed, naturally occurring set of regulatory molecules proven effective for diabetes, lupus, arthritis, fibromyalgia, and some forms of cancer is making medical history.

(PRWEB) April 25, 2005 -- Biogenic Nutraceuticals has announced that it has been appointed as the exclusive, licensed, international distributor for the products of Berean Development, Inc., an emerging biotechnology company focusing on the development and commercialization of naturally occurring compounds for the treatment of Diabetes, Lupus, Fibromyalgia, Arthritis and Cancer. Bereans main patented, non-presciption products are Mirac®, for lupus, rheumatoid arthritis, fibromyalgia, and certain types of cancer; and Allbaid® for diabetes.

Science driven Mirac® is a specially designed, naturally occurring set of regulatory molecules proven effective for lupus, arthritis, fibromyalgia, and some forms of cancer. Mirac® is a safe, non-toxic bioflavonoid complex whose mechanism of activity targets the blocking of ion channels in certain lymphocytes. Lupus is caused by Natural Killer (NK) CD4-- and CD8-- T-Lymphocytes, also called T-cells. These T-cells multiply using a potassium gene channel. These same cells cause diabetes. By blocking these ion channels, Mirac® prevents the cascade of events leading to inflammatory responses seen in autoimmune and neuroinflammatory type diseases such as lupus.

The efficacy of each of these products is well supported by highly qualified doctors, scientific research, and actual clinical and/or blood tests. Both Mirac® and Allbaid® have been approved under the Dietary Supplements Health Education Act of 1994 (DSHEA") as being safe and free of side effects with one exception: people with an allergic reaction to pineapple cannot take Mirac.

Physicians working in the field of Rheumatology, or with diseases of the autoimmune system, or individuals suffering from an inflammatory disease such as lupus, rheumatoid arthritis, fibromyalgia; some forms of cancer; or diabetes; should seriously consider these ground-breaking products.

# # #


See the original story at: http://www.prweb.com/releases/2005/04/prweb232677.htm
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
David Glen
Biogenic Nutraceuticals
949-477-4949
Email us Here

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright